Tag: Mycobacterium avium complex

Arikayce (amikacin liposome inhalation suspension) is an add-on therapy approved by the FDA for adults with refractory *Mycobacterium avium* complex (MAC) lung disease, a condition that has not responded to initial treatment. However, many other antibiotic combinations and treatment strategies exist for both initial and refractory MAC, providing important alternatives for managing this chronic infection.

ARIKAYCE (amikacin liposome inhalation suspension) was first approved by the FDA on September 28, 2018 [1.2.5]. Currently, **is there a generic for ARIKAYCE?** No, ARIKAYCE is only available as a brand-name medication and does not have a generic version [1.2.1, 1.3.4].

Ethambutol is a potent oral chemotherapeutic agent specifically effective against actively growing microorganisms of the genus *Mycobacterium*, which is why **what is ethambutol used for?** is a critical question in treating infectious diseases. It is most commonly used as a cornerstone in multi-drug regimens to treat and manage tuberculosis and other serious mycobacterial infections.